Cardinal Health Latest News

From the Wall Street Journal: Cardinal Health plans to test the use of drones with Zipline International Inc. to deliver medications, inhalers and other items to U.S. pharmacies – with the goal...

By Debbie Weitzman, President, Pharmaceutical Distribution The healthcare landscape is rapidly evolving, and Cardinal Health remains committed to supply chain excellence and high-impact solutions...

By Heidi Hunter, President, Cardinal Health Specialty Solutions Lately, I’ve been talking with colleagues about how to find the balance between focusing on the needs of the here-and-now, while...

By Mike Kaufmann, Cardinal Health CEO Supply chain disruption. It’s everywhere and it’s impacting all of us. Every corner of the supply chain is experiencing unprecedented challenges – from...

By Heidi Hunter, President, Cardinal Health Specialty Solutions at Cardinal Health This week marks Global Biosimilars Week – a time when healthcare stakeholders around the world are raising...

Medications that drive competition, lower costs and increase accessibility Biologics are the fastest growing class of drugs in the U.S.; they bring innovative, life-changing treatments to patients...

Fuse, the innovation engine and product development center at Cardinal Health, is an open, collaborative and creative habitat where software engineers, clinical experts, data scientists and...

By Brian Rice, EVP, CIO and Customer Support Services at Cardinal Health As the world prepared for the COVID-19 vaccine rollout last winter, we identified a gap that could limit the ability of...

Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce...

New tool is designed to help pharmacies navigate state-by-state interchangeability laws for the FDA’s new regulatory designation Cardinal Health has created an interactive tool that provides...

Change has been the one constant in nuclear medicine from the beginning, with the steady arrival of new radiopharmaceuticals, new technologies and an evolving regulatory environment. Today, as...

Our chief strategy officer, Michele Holcomb, spoke with Forbes about the deep connection between diversity, equity and inclusion (DE&I) and innovation. “My view of innovation was formed early in...

In December 2020, the FDA announced that a new radioactive diagnostic agent, Gallium 68 (Ga-68) PSMA-11, could be prescribed and administered to patients with suspected prostate cancer metastasis...

Last year, a critical need for life-saving blood and plasma donations arose with two major complications: an extraordinary decrease in blood donations due to the COVID-19 pandemic, and...